Cancer remains the second leading cause of death globally, accounting for approximately 9.6 million deaths in 2018 alone—about 1 in 6 deaths—according to the World Health Organization (WHO). While these figures are alarming, early detection dramatically improves treatment success and survival rates. One of the most promising strategies for early diagnosis is through blood tests, which can detect cancer-related changes before symptoms even appear. These tests analyze biomarkers such as proteins, circulating tumor cells, and DNA fragments to flag potential malignancies. Below are some key blood tests that show significant promise in detecting various cancers in both men and women.
Complete Blood Count (CBC)
The CBC test measures various components of your blood, including red blood cells, white blood cells, and platelets. It also checks hemoglobin levels and red blood cell size. Doctors use this test to identify blood-related cancers like leukemia and lymphoma. An abnormal CBC result can indicate disruptions in normal blood cell production, often caused by cancer or other health conditions.
Circulating Tumor Cell (CTC) Test
The CTC test, a type of liquid biopsy, detects tumor cells that have broken away from a primary tumor and entered the bloodstream. This test is especially helpful in cases of metastatic breast, prostate, or colon cancer. A higher number of circulating tumor cells often correlates with a more aggressive disease and poorer prognosis.
Blood Chemistry Test
As reported by TOI, this test measures the levels of substances such as enzymes, fats, sugars, proteins, and electrolytes in your blood. It also provides insights into the functioning of organs like the liver and kidneys. Abnormalities in these values may suggest the presence of cancer or damage caused by a tumor in specific organs.
Immunophenotyping
Immunophenotyping identifies cells based on specific markers or antigens on their surfaces. Doctors use this test to determine whether malignant cells originated from B lymphocytes or T lymphocytes. It plays a crucial role in diagnosing blood cancers such as leukemia and lymphoma by comparing cancerous cells to healthy immune cells.
Liquid Biopsy
Liquid biopsy is a cutting-edge technique that detects tumor cells and fragments of tumor DNA circulating in the blood. This test can uncover cancer at its earliest stages, even when tumors are too small to be found through imaging. It’s non-invasive, repeatable, and especially useful for monitoring cancer progression or recurrence.
Blood Protein Test
This test evaluates the presence and levels of specific proteins in the blood. Abnormally high protein levels can signal blood cancers like leukemia, lymphoma, or multiple myeloma. However, doctors typically order follow-up tests to confirm a diagnosis, as protein imbalances can result from various non-cancerous conditions.
Tumor Marker Blood Tests
Tumor marker tests detect substances produced either by cancer cells or by the body in response to cancer. Elevated levels of these markers may point to certain types of cancers. These tests not only help in diagnosing cancer but also in monitoring treatment effectiveness and potential recurrence.
The Bottom Line
Although no single blood test can definitively diagnose all types of cancer, these diagnostic tools offer a crucial advantage: the ability to detect the disease early, often before symptoms develop. As research progresses, these tests are becoming more accurate and accessible, holding great promise in the fight against cancer. Regular screenings, combined with medical guidance, remain the best approach for early detection and improved survival outcomes.